SCM
Suvretta Capital Management Portfolio holdings
AUM
$3.3B
1-Year Est. Return
34.1%
1 Year Est. Return
+34.1%
AUM
$2.65B
AUM Growth
+$183M
(+7.4%)
Holding
111
Top Buys
| 1 | +$57.8M | |
| 2 | +$51.5M | |
| 3 | +$39.4M | |
| 4 |
Danaher
DHR
|
+$31.8M |
| 5 |
GE Aerospace
GE
|
+$28.2M |
Top Sells
| 1 | +$126M | |
| 2 | +$92.5M | |
| 3 | +$40.4M | |
| 4 |
United Airlines
UAL
|
+$28.3M |
| 5 |
Chipotle Mexican Grill
CMG
|
+$27.1M |
Sector Composition
| 1 | Healthcare | 61.21% |
| 2 | Technology | 12.36% |
| 3 | Consumer Discretionary | 7.05% |
| 4 | Financials | 6.14% |
| 5 | Communication Services | 5.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Capital One
COF
$134B
| $41.3M | 1.25% |
194,160
-51,062
|
|
||
27
Ferguson
FERG
$48.7B
| $41.3M | 1.25% |
189,660
+59,736
|
|
||
28
GE HealthCare
GEHC
$33.3B
| $39.4M | 1.19% |
+532,280
|
|
||
29
Boston Scientific
BSX
$152B
| $38M | 1.14% |
353,561
+91,462
|
|
||
30
Fulcrum Therapeutics
FULC
$468M
| $35M | 1.05% |
5,082,900
+15,506
|
|
||
|
31
Danaher
DHR
$156B
| $34.5M | 1.04% |
174,700
+161,100
|
|
||
32
Arcus Biosciences
RCUS
$2.48B
| $30M | 0.91% |
3,688,858
+1,127,954
|
|
||
33
Tesla
TSLA
$1.34T
| $29.3M | 0.88% |
92,357
-29,659
|
|
||
34
Aura Biosciences
AURA
$344M
| $27.4M | 0.83% |
4,372,884
+1,640,998
|
|
||
35
Insmed
INSM
$41.2B
| $24M | 0.72% |
238,783
-1,253,600
|
|
||
36
Datadog
DDOG
$64.9B
| $24M | 0.72% |
178,832
-4,399
|
|
||
37
Mineralys Therapeutics
MLYS
$3.23B
| $23.6M | 0.71% |
1,744,492
+76,733
|
|
||
38
UnitedHealth
UNH
$292B
| $21.2M | 0.64% |
68,000
+38,100
|
|
||
39
Johnson & Johnson
JNJ
$472B
| $20.3M | 0.61% |
132,786
+23,400
|
|
||
40
Biogen
BIIB
$24.6B
| $19.1M | 0.58% |
151,890
+31,154
|
|
||
41
Compass Therapeutics
CMPX
$859M
| $18.6M | 0.56% |
+7,149,493
|
|
||
42
Erasca
ERAS
$732M
| $18.4M | 0.56% |
14,502,004
+2,187,000
|
|
||
43
Merck
MRK
$231B
| $17.4M | 0.52% |
219,178
+75,078
|
|
||
44
Goldman Sachs
GS
$237B
| $17.1M | 0.51% |
24,108
-1,430
|
|
||
|
PVLA
45
Palvella Therapeutics
PVLA
$991M
| $16.1M | 0.49% |
714,463
|
|
||
46
Pinterest
PINS
$18B
| $15.4M | 0.46% |
+430,025
|
|
||
47
Abeona Therapeutics
ABEO
$228M
| $15.2M | 0.46% |
2,676,000
-1,009,503
|
|
||
48
Monte Rosa Therapeutics
GLUE
$935M
| $15.2M | 0.46% |
3,360,000
+1,796,202
|
|
||
49
Moderna
MRNA
$9.68B
| $14.3M | 0.43% |
517,163
|
|
||
50
Kymera Therapeutics
KYMR
$4.67B
| $12M | 0.36% |
+275,000
|
|